Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-04-05
1996-08-13
Criares, Theodore J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514253, 514256, 514333, 514339, 514361, 514362, 514363, 514365, 514372, 514374, 514378, 514397, 514406, 514411, 514418, 544405, A61K 3140, A61K 31495, A61K 31505, A61K 3144, A61K 3141, A61K 31425, A61K 3142, A61K 31415
Patent
active
055456561
ABSTRACT:
This invention relates to the use of certain 3-substituted 2-oxindole-1-carboxamides and their pharmaceutically acceptable base salts for the treatment or prevention of Alzheimer's disease in mammals, including humans.
REFERENCES:
patent: 4556672 (1985-12-01), Kadin
patent: 4853409 (1989-08-01), Showell
patent: 4861794 (1989-08-01), Otterness
patent: 5006547 (1991-04-01), Loose
patent: 5008283 (1991-04-01), Blackburn
patent: 5122534 (1992-06-01), Loose
patent: 5290802 (1994-03-01), Ehrgott
McGeer et al., Neurology, 42, 447-9, (1992).
Rogers et al., Neurology, 43, 1609-11, (1993).
Lombardino Joseph G.
Loose Leland D.
Weiner Ethan S.
Criares Theodore J.
DeBenedicts Karen
Ginsburg Paul H.
Pfizer Inc.
Richardson Peter C.
LandOfFree
2-Oxidole-1-carboxamide pharmaceutical agents for the treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-Oxidole-1-carboxamide pharmaceutical agents for the treatment , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-Oxidole-1-carboxamide pharmaceutical agents for the treatment will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1048162